Get started
Author

Swanand Kulkarni

Observed names: Kulkarni Swanand Sanjay, Kulkarni, Swanand
ORCID: 0000-0002-0237-3826
Observed ORCID: 0000-0002-0237-3826
OpenAlex ID: A5077315898
Polycystic ovary syndrome: Current scenario and future insights
2023 · Swanand Kulkarni, Khushi Gupta, et al. · Drug Discovery Today · 52
Flavonoids as promising anticancer agents: anin silicoinvestigation of ADMET, binding affinity by molecular docking and molecular dynamics simulations
2022 · Avadh Biharee, Arpita Yadav, et al. · Journal of Biomolecular Structure and Dynamics · 30
Boron in cancer therapeutics: An overview
2023 · Swanand Kulkarni, Dyuti Bhandary, et al. · Pharmacology & Therapeutics · 28
Selective Estrogen Receptor Modulators (SERMs) for the treatment of ER+ breast cancer: An overview
2022 · Sweety Das, Swanand Kulkarni, et al. · Journal of Molecular Structure · 25
Recent Developments in Oxazole Derivatives as Anticancer Agents: Review on Synthetic Strategies, Mechanism of Action and SAR Studies
2021 · Vikas Jaitak, Swanand Kulkarni, et al. · Anti-Cancer Agents in Medicinal Chemistry · 25
Recent Advancements in the Discovery of MDM2/MDM2-p53 Interaction Inhibitors for the Treatment of Cancer
2022 · Neha Bhatia, Rakesh Khator, et al. · Current Medicinal Chemistry · 18
Molecular dynamics and 3D-QSAR studies on indazole derivatives as HIF-1α inhibitors
2022 · Yogesh Singh, Kulkarni Swanand Sanjay, et al. · Journal of Biomolecular Structure and Dynamics · 18
Medicinal chemistry aspects and synthetic strategies of coumarin as aromatase inhibitors: an overview
2022 · Pooja Ratre, Swanand Kulkarni, et al. · Medical Oncology · 16
Mechanistic analysis of diverse click reactions along with their applications
2025 · Sushmita Bhatia, Avadh Biharee, et al. · European Journal of Medicinal Chemistry · 15
An amalgamated molecular dynamic and Gaussian based 3D-QSAR study for the design of 2,4-thiazolidinediones as potential PTP1B inhibitors
2023 · Avadh Biharee, Yogesh Singh, et al. · Journal of Molecular Graphics and Modelling · 14
Molecular docking, 3D-QSAR and simulation studies for identifying pharmacophoric features of indole derivatives as 17β-hydroxysteroid dehydrogenase type 5 (17β-HSD5) inhibitors
2023 · Swanand Kulkarni, Yogesh Singh, et al. · Journal of Biomolecular Structure and Dynamics · 14
Phosphate Prodrugs: An Approach to Improve the Bioavailability of Clinically Approved Drugs
2023 · Tanmoy Tantra, Yogesh Singh, et al. · Current Medicinal Chemistry · 12
Medicinal Aspects of PTP1B Inhibitors as Anti-Breast Cancer Agents: An Overview
2023 · Rakesh Khator, Avadh Biharee, et al. · Current Medicinal Chemistry · 11
Developing our knowledge of the quinolone scaffold and its value to anticancer drug design
2023 · Yogesh Singh, Neha Bhatia, et al. · Expert Opinion on Drug Discovery · 11
Pharmacophore derived 3D-QSAR, molecular docking, and simulation studies of quinoxaline derivatives as ALR2 inhibitors
2023 · Yogesh Singh, Niraj Kumar, et al. · Journal of Biomolecular Structure and Dynamics · 4
Animal models of polycystic ovary syndrome
2025 · Swanand Kulkarni, Dnyanesh Dahake, et al. · Systems Biology in Reproductive Medicine · 3
Anti-androgenic and anti-proliferative properties of methanolic leaf extract of Allamanda cathartica Linn. in adult mouse testis: Evidences from in vivo and in silico studies
2025 · Rakesh Raman, Rimple Kaur, et al. · The Journal of Steroid Biochemistry and Molecular Biology · 2
Thioether linkage chemistry: perspectives and prospects in therapeutic designing
2023 · Yogesh Singh, Swanand Kulkarni, et al. · Elsevier eBooks · 2
Precision targeting in prostate cancer: Mechanistic drivers and the evolving clinical pipeline
2026 · Pratiksha Nathe, Yogesh Singh, et al. · Drug Discovery Today
Progress in 17β-HSD5 Inhibitor Discovery: Mechanistic Basis, SAR Trends, and Therapeutic Potential
2026 · Suyash Torawane, Pooja Ratre, et al. · Journal of Molecular Structure
Recent Developments in Common Dietary Phytoconstituents: Insights into Structure-activity Relationship and Anti-breast Cancer Activity
2026 · Kumari Sunita Prajapati, Swanand Kulkarni, et al. · Mini-Reviews in Medicinal Chemistry
Contributors
2023 · Mansour H. Almatarneh, Rajendra Awasthi, et al. · Elsevier eBooks
Flavonoids as promising anticancer agents: an in silico investigation of ADMET, binding affinity by molecular docking and molecular dynamics simulations
2022 · Biharee, Avadh, Yadav, Arpita, et al. · Figshare
Works count: 24
Citation count: 300
H-index: 12
I10-index: 14
Year
Topic
Type